How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/glioblastoma-multiforme-of-brain.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Glioblastoma multiforme of brain — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Glioblastoma multiforme of brain (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Glioblastoma multiforme of brain, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Temodar	temozolomide	Merck & Co.	Alkylating Drug [EPC]		1999-01-01
Gliadel	CARMUSTINE	Avet Lifesciences	Alkylating Drug	Glutathione reductase, mitochondrial	1977-01-01
Carmustin	Carmustin	University Hospital Freiburg		Glutathione reductase, mitochondrial
Temodal	Temodal	Armando Santoro, MD

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Armando Santoro, MD · 1 drug in Glioblastoma multiforme of brain
Avet Lifesciences · 1 drug in Glioblastoma multiforme of brain
Merck & Co. · 1 drug in Glioblastoma multiforme of brain
University Hospital Freiburg · 1 drug in Glioblastoma multiforme of brain

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Glioblastoma multiforme of brain:

Cite this brief

Drug Landscape (2026). Glioblastoma multiforme of brain — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/glioblastoma-multiforme-of-brain. Accessed 2026-06-10.

Glioblastoma multiforme of brain full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing